Spectral Medical Inc. (EDTXF)
USD 0.57
(-3.03%)
USD 0.57
(-3.03%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 5.6 Million CAD | 417.07% |
| 2022 | -1.76 Million CAD | 78.71% |
| 2021 | -8.3 Million CAD | -61.63% |
| 2020 | -5.14 Million CAD | -643.85% |
| 2019 | -691 Thousand CAD | 84.18% |
| 2018 | -4.36 Million CAD | -201.45% |
| 2017 | -1.44 Million CAD | 71.48% |
| 2016 | -5.08 Million CAD | 20.24% |
| 2015 | -6.36 Million CAD | 36.65% |
| 2014 | -10.05 Million CAD | -39.08% |
| 2013 | -7.22 Million CAD | -33.25% |
| 2012 | -5.42 Million CAD | 59.73% |
| 2011 | -13.47 Million CAD | -30.64% |
| 2010 | -10.31 Million CAD | -1595.89% |
| 2009 | -608 Thousand CAD | -132.43% |
| 2008 | 1.87 Million CAD | 36.86% |
| 2007 | 1.37 Million CAD | 52.56% |
| 2006 | 898 Thousand CAD | -87.13% |
| 2005 | 6.97 Million CAD | 21.11% |
| 2004 | 5.76 Million CAD | -14.66% |
| 2003 | 6.75 Million CAD | 1257.98% |
| 2002 | -583 Thousand CAD | -154.54% |
| 2001 | 1.06 Million CAD | 197.18% |
| 2000 | -1.1 Million CAD | 75.56% |
| 1999 | -4.5 Million CAD | 68.09% |
| 1998 | -14.1 Million CAD | 50.18% |
| 1997 | -28.3 Million CAD | -60.8% |
| 1996 | -17.6 Million CAD | 45.0% |
| 1995 | -32 Million CAD | -229.9% |
| 1994 | -9.7 Million CAD | -259.26% |
| 1993 | -2.7 Million CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 7.18 Million CAD | 28.15% |
| 2024 Q2 | 5.51 Million CAD | -23.26% |
| 2023 Q3 | 7.25 Million CAD | 81.85% |
| 2023 Q2 | 3.99 Million CAD | 128.0% |
| 2023 Q4 | 5.6 Million CAD | -22.7% |
| 2023 FY | 5.6 Million CAD | 417.07% |
| 2023 Q1 | 1.75 Million CAD | 198.93% |
| 2022 Q4 | -1.76 Million CAD | -160.91% |
| 2022 Q1 | -5.91 Million CAD | 28.84% |
| 2022 Q2 | -2.92 Million CAD | 50.46% |
| 2022 Q3 | -678 Thousand CAD | 76.85% |
| 2022 FY | -1.76 Million CAD | 78.71% |
| 2021 Q4 | -8.3 Million CAD | 19.49% |
| 2021 Q1 | -4.55 Million CAD | 11.34% |
| 2021 Q2 | -3.74 Million CAD | 17.82% |
| 2021 Q3 | -10.31 Million CAD | -175.54% |
| 2021 FY | -8.3 Million CAD | -61.63% |
| 2020 Q2 | -9.52 Million CAD | -35.15% |
| 2020 Q3 | -6.88 Million CAD | 27.67% |
| 2020 FY | -5.14 Million CAD | -643.85% |
| 2020 Q1 | -7.04 Million CAD | -919.68% |
| 2020 Q4 | -5.14 Million CAD | 25.38% |
| 2019 Q1 | -3.81 Million CAD | 12.61% |
| 2019 Q3 | -2.21 Million CAD | 26.59% |
| 2019 Q4 | -691 Thousand CAD | 68.83% |
| 2019 FY | -691 Thousand CAD | 84.18% |
| 2019 Q2 | -3.02 Million CAD | 20.88% |
| 2018 FY | -4.36 Million CAD | -201.45% |
| 2018 Q2 | -5.22 Million CAD | -431.77% |
| 2018 Q3 | -4.56 Million CAD | 12.54% |
| 2018 Q1 | -982 Thousand CAD | 32.23% |
| 2018 Q4 | -4.36 Million CAD | 4.36% |
| 2017 Q4 | -1.44 Million CAD | 36.2% |
| 2017 FY | -1.44 Million CAD | 71.48% |
| 2017 Q3 | -2.27 Million CAD | 22.01% |
| 2017 Q2 | -2.91 Million CAD | 21.59% |
| 2017 Q1 | -3.71 Million CAD | 26.89% |
| 2016 FY | -5.08 Million CAD | 20.24% |
| 2016 Q2 | -10.04 Million CAD | 21.9% |
| 2016 Q4 | -5.08 Million CAD | 29.25% |
| 2016 Q3 | -7.18 Million CAD | 28.51% |
| 2016 Q1 | -12.86 Million CAD | -101.93% |
| 2015 Q4 | -6.36 Million CAD | 24.21% |
| 2015 FY | -6.36 Million CAD | 36.65% |
| 2015 Q3 | -8.4 Million CAD | 23.15% |
| 2015 Q2 | -10.93 Million CAD | -54.73% |
| 2015 Q1 | -7.06 Million CAD | 29.7% |
| 2014 Q3 | -11.7 Million CAD | -711.94% |
| 2014 Q4 | -10.05 Million CAD | 14.07% |
| 2014 FY | -10.05 Million CAD | -39.08% |
| 2014 Q1 | -3.73 Million CAD | 48.4% |
| 2014 Q2 | -1.44 Million CAD | 61.37% |
| 2013 FY | -7.22 Million CAD | -33.25% |
| 2013 Q3 | -3.85 Million CAD | 29.38% |
| 2013 Q4 | -7.22 Million CAD | -87.52% |
| 2013 Q2 | -5.45 Million CAD | -127.17% |
| 2013 Q1 | -2.4 Million CAD | 55.71% |
| 2012 FY | -5.42 Million CAD | 59.73% |
| 2012 Q4 | -5.42 Million CAD | 23.53% |
| 2012 Q2 | -9.22 Million CAD | 15.18% |
| 2012 Q3 | -7.09 Million CAD | 23.11% |
| 2012 Q1 | -10.87 Million CAD | 19.25% |
| 2011 Q3 | -15.19 Million CAD | -116.56% |
| 2011 Q4 | -13.47 Million CAD | 11.36% |
| 2011 Q1 | -8.54 Million CAD | 17.11% |
| 2011 FY | -13.47 Million CAD | -30.64% |
| 2011 Q2 | -7.01 Million CAD | 17.9% |
| 2010 Q1 | -17.93 Million CAD | -2849.51% |
| 2010 FY | -10.31 Million CAD | -1595.89% |
| 2010 Q4 | -10.31 Million CAD | 31.42% |
| 2010 Q2 | -16.04 Million CAD | 10.55% |
| 2010 Q3 | -15.03 Million CAD | 6.28% |
| 2009 Q4 | -608 Thousand CAD | 80.53% |
| 2009 Q3 | -3.12 Million CAD | -277.08% |
| 2009 FY | -608 Thousand CAD | -132.43% |
| 2009 Q2 | 1.76 Million CAD | -31.72% |
| 2009 Q1 | 2.58 Million CAD | 37.71% |
| 2008 Q3 | 1.95 Million CAD | -14.01% |
| 2008 Q4 | 1.87 Million CAD | -4.24% |
| 2008 FY | 1.87 Million CAD | 36.86% |
| 2008 Q2 | 2.27 Million CAD | 16.95% |
| 2008 Q1 | 1.94 Million CAD | 42.12% |
| 2007 Q2 | 1.94 Million CAD | 32.52% |
| 2007 Q4 | 1.37 Million CAD | -40.82% |
| 2007 Q1 | 1.46 Million CAD | 0.0% |
| 2007 FY | 1.37 Million CAD | 52.56% |
| 2007 Q3 | 2.31 Million CAD | 19.08% |
| 2006 FY | 898 Thousand CAD | -87.13% |
| 2006 Q3 | -4.15 Million CAD | 8.45% |
| 2006 Q2 | -4.54 Million CAD | -181.23% |
| 2006 Q1 | 5.59 Million CAD | -42.95% |
| 2005 FY | 6.97 Million CAD | 21.11% |
| 2005 Q4 | 9.8 Million CAD | 10.27% |
| 2005 Q1 | 6.97 Million CAD | 30.63% |
| 2005 Q2 | 8.26 Million CAD | 18.47% |
| 2005 Q3 | 8.89 Million CAD | 7.56% |
| 2004 Q3 | 7.56 Million CAD | 3.11% |
| 2004 Q2 | 7.33 Million CAD | 27.37% |
| 2004 Q4 | 5.34 Million CAD | -29.41% |
| 2004 FY | 5.76 Million CAD | -14.66% |
| 2004 Q1 | 5.76 Million CAD | 168.58% |
| 2003 Q1 | 6.75 Million CAD | 60.55% |
| 2003 FY | 6.75 Million CAD | 1257.98% |
| 2003 Q4 | 2.14 Million CAD | 210.51% |
| 2003 Q3 | -1.94 Million CAD | -128.96% |
| 2003 Q2 | 6.7 Million CAD | -0.73% |
| 2002 Q4 | 4.2 Million CAD | -27.57% |
| 2002 Q2 | 333 Thousand CAD | 157.12% |
| 2002 Q1 | -583 Thousand CAD | 62.91% |
| 2002 FY | -583 Thousand CAD | -154.54% |
| 2002 Q3 | 5.8 Million CAD | 1643.54% |
| 2001 Q2 | 3.91 Million CAD | 266.6% |
| 2001 Q1 | 1.06 Million CAD | 22.73% |
| 2001 Q3 | -2.97 Million CAD | -175.94% |
| 2001 Q4 | -1.57 Million CAD | 47.18% |
| 2001 FY | 1.06 Million CAD | 197.18% |
| 2000 Q3 | -263 Thousand CAD | 82.47% |
| 2000 FY | -1.1 Million CAD | 75.56% |
| 2000 Q2 | -1.5 Million CAD | -36.36% |
| 2000 Q4 | 871 Thousand CAD | 431.18% |
| 2000 Q1 | -1.1 Million CAD | 8.33% |
| 1999 Q1 | -4.5 Million CAD | 28.57% |
| 1999 Q4 | -1.2 Million CAD | 53.85% |
| 1999 FY | -4.5 Million CAD | 68.09% |
| 1999 Q3 | -2.6 Million CAD | 35.0% |
| 1999 Q2 | -4 Million CAD | 11.11% |
| 1998 Q3 | -10.6 Million CAD | -0.95% |
| 1998 Q2 | -10.5 Million CAD | 25.53% |
| 1998 FY | -14.1 Million CAD | 50.18% |
| 1998 Q4 | -6.3 Million CAD | 40.57% |
| 1998 Q1 | -14.1 Million CAD | 18.5% |
| 1997 Q3 | -20.7 Million CAD | 14.46% |
| 1997 Q4 | -17.3 Million CAD | 16.43% |
| 1997 Q1 | -28.3 Million CAD | -51.34% |
| 1997 FY | -28.3 Million CAD | -60.8% |
| 1997 Q2 | -24.2 Million CAD | 14.49% |
| 1996 Q2 | -24.9 Million CAD | -41.48% |
| 1996 Q3 | -22.1 Million CAD | 11.24% |
| 1996 FY | -17.6 Million CAD | 45.0% |
| 1996 Q1 | -17.6 Million CAD | 17.37% |
| 1996 Q4 | -18.7 Million CAD | 15.38% |
| 1995 Q2 | -27.9 Million CAD | 12.81% |
| 1995 Q4 | -21.3 Million CAD | 17.76% |
| 1995 FY | -32 Million CAD | -229.9% |
| 1995 Q1 | -32 Million CAD | 8.57% |
| 1995 Q3 | -25.9 Million CAD | 7.17% |
| 1994 Q2 | -38.2 Million CAD | -293.81% |
| 1994 Q1 | -9.7 Million CAD | 0.0% |
| 1994 FY | -9.7 Million CAD | -259.26% |
| 1994 Q4 | -35 Million CAD | 5.15% |
| 1994 Q3 | -36.9 Million CAD | 3.4% |
| 1993 FY | -2.7 Million CAD | 0.0% |
| 1993 Q1 | -2.7 Million CAD | 21.7% |
| 1992 Q4 | -3.44 Million CAD | 30.92% |
| 1992 Q2 | 119.61 Thousand CAD | 0.0% |
| 1992 Q3 | -4.99 Million CAD | -4272.72% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | -154.261% |
| Arrayit Corporation | 1.05 Million USD | -431.367% |
| Atlantic International Corp. | 236.49 Thousand USD | -2271.71% |
| Biocept, Inc. | -788 Thousand USD | 811.802% |
| Bioqual, Inc. | -12 Million USD | 146.714% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | -24566.872% |
| DermTech, Inc. | 17.65 Million USD | 68.226% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 100.98% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 176.035% |
| iMD Companies, Inc. | 1.11 Million USD | -402.637% |
| IDenta Corp. | 524.85 Thousand USD | -968.682% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 27.099% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | 20911.072% |
| InVitro International | -313.14 Thousand USD | 1891.2% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | -258.193% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | 786776.017% |
| Medical Imaging Corp. | 3.79 Million USD | -47.958% |
| NovelStem International Corp. | 3.52 Million USD | -59.277% |
| Optigenex Inc. | 8.93 Million USD | 37.217% |
| PharmChem, Inc. | -1.49 Million USD | 475.331% |
| Proteome Sciences plc | 14.57 Million USD | 61.512% |
| Response Genetics, Inc | -13.08 Million USD | 142.863% |
| Rennova Health, Inc. | 14.82 Million USD | 62.178% |
| RushNet, Inc. | 4.8 Million USD | -16.834% |
| ScreenPro Security Inc. | 135.58 Thousand USD | -4036.766% |
| Stella Diagnostics Inc. | 6.19 Million USD | 9.431% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | -214.336% |
| Todos Medical Ltd. | 38.31 Million USD | 85.36% |